Anti-H7N9 hIgG4 Antibody(mAb3)

Moreover, antibodies against H7N9 can also be used to treat infected individuals. By developing monoclonal antibodies, these antibodies can enhance the immune response of the infected person, improving their ability to fend off the pathogen. Therefore, the dual application of H7N9 antibodies in vaccine development and treatment is crucial in combating H7N9 virus infections and can provide strong support for public health responses.